Humanoid-universe.com

Been lurking on this one for a while, finally decided to ask. Self-reported deployment and uptime numbers from humanoid companies are inherently hard to independently verify, since there's no standardized, third-party reporting requirement yet - a healthy dose of skepticism toward company press releases is reasonable until independent data catches up. Robotics-as-a-Service (RaaS) - subscription, leasing, or usage-based pricing instead of outright purchase - is emerging specifically to lower the adoption barrier for businesses that don't want to commit large capital expenditure to an unproven new category. Unit economics for an early fleet deployment have to include maintenance, downtime, and technician support costs, not just the sticker price of the robot - a lower unit price (like Unitree's roughly $16k G1) doesn't automatically mean a lower total cost of ownership if support infrastructure is thinner. Curious to hear how others see this.

@servosan90 Slightly off-topic, but related: A recurring critique worth taking seriously: a lot of publicly announced 'production capacity' targets (100k units/year, 1 million/year by 2028, etc.) are aspirational manufacturing targets, not confirmed sales or deployment numbers, and the gap between the two has historically been large in hardware industries.

Just to be precise about one thing: Global humanoid robotics funding reached roughly $8.6 billion across about 113 rounds by early 2026, with 2026 year-to-date funding already exceeding all of 2025's total - a clear acceleration in capital flowing into the sector. The 'labor shortage' framing in a lot of humanoid robotics pitch decks is doing real narrative work - it's a genuinely true dynamic in some sectors like warehousing and logistics, but it's also a much more palatable framing than 'labor cost reduction,' and both are usually true simultaneously.

From hands-on experience, Pilot-to-contract conversion rate is one of the most important and least publicly available numbers in this industry - a company running many flashy pilots isn't the same as a company converting those pilots into multi-year recurring revenue.

Slightly off-topic, but related: Late-stage funding rounds, essentially absent before 2025, became a defining feature of the market with roughly $1.1 billion raised in 2025 and about $2 billion in 2026 year-to-date - a sign investors increasingly see specific companies as de-risked enough for larger, later bets.

Genuine beginner question - Automotive OEMs becoming the leading early-adopter vertical isn't really about cars specifically - it's about those companies already having structured facilities, existing automation budgets, and risk tolerance for piloting new equipment at scale.

@betty.king I'd push back on this a bit. Chinese humanoid startups reportedly accounted for around 65% of deal volume in 2025, while US companies still won the largest individual rounds, with at least three raises exceeding $400 million - deal count and deal size tell different stories depending on which region you're looking at.

I don't think that's quite right, for what it's worth. Q1 2026 alone saw about $2.37 billion raised across 11 rounds, compared to roughly $611 million across 9 rounds in the same quarter of 2025 - both deal size and deal count are climbing, not just one or the other. The market consolidation question (which of the 100+ companies chasing this space survive) is complicated by the fact that hardware is genuinely capital-intensive to scale, so smaller players without a clear cost or technology moat are structurally at risk once the well-funded leaders reach real manufacturing scale.

Just to be precise about one thing: The humanoid robot market is estimated at roughly $5.41 billion in 2026, with projections reaching around $50 billion by 2035 (about 28% CAGR) - a genuinely huge projected growth curve, and also exactly the kind of number worth treating with healthy skepticism given how young and unproven the underlying revenue base still is.

This lines up with my experience. Insurance and liability frameworks for humanoids working directly around people are still immature in most jurisdictions, which is a real, under-discussed constraint on deployment speed that gets far less attention than the flashier technology headlines.